Pseudoxanthoma elasticum is a complex genetic disorder that requires lifelong attention to multiple organ systems, from the skin to the eyes and blood vessels. While there is no cure, a combination of standard therapies and emerging treatments tested in research settings offers hope for better symptom management and improved quality of life for those affected.

The Path to Better Management: Understanding Treatment Goals

When someone receives a diagnosis of pseudoxanthoma elasticum (often called PXE), the journey toward managing this condition begins with understanding what treatment can realistically achieve. The primary focus of all therapeutic approaches is to slow down the progression of symptoms, prevent serious complications, and maintain the best possible quality of life. Because PXE affects multiple body systems—including skin, eyes, and blood vessels—treatment must be coordinated across different medical specialties, with each addressing specific manifestations of the disease.^[1]

The approach to treating PXE is highly individualized. What works for one person may not be appropriate for another, depending on which organs are most affected and how rapidly the disease progresses. Some individuals may experience primarily cosmetic skin changes with minimal impact on vision or cardiovascular health, while others face more significant challenges requiring intensive monitoring and intervention. This variability means that treatment plans must be tailored to each person’s unique situation, taking into account their age, the severity of symptoms, and the presence of complications.^[2]

Current medical guidelines recognize both established therapies that have been used for years and newer approaches being evaluated in clinical research. Standard treatments address symptoms as they arise, focusing on managing eye problems, preventing cardiovascular complications, and supporting overall health through lifestyle modifications. Meanwhile, scientists continue to investigate innovative therapies that might target the underlying metabolic problems causing PXE, offering hope that future treatments could be more effective at slowing or even preventing disease progression.^[10]

Established Approaches: How Standard Treatment Works Today

The cornerstone of standard PXE treatment involves careful monitoring and symptom-specific interventions rather than a single medication that addresses all aspects of the disease. This is because PXE is fundamentally a metabolic disorder where the body cannot properly regulate calcium and mineral deposits in elastic tissues, and no medication has yet been approved that can correct this underlying problem.^[15]

Managing Eye Complications

For many people with PXE, vision problems represent the most significant concern. The disease causes breaks in a membrane called Bruch’s membrane in the eye, creating streaks called angioid streaks. While these streaks themselves do not cause vision loss, they can allow abnormal blood vessels to grow and leak, potentially leading to central vision loss if they affect the macula—the part of the retina responsible for detailed central vision.^[3]

When these leaky blood vessels develop, a condition called choroidal neovascularization, doctors use injections of anti-VEGF medications (substances that block vascular endothelial growth factor, a protein that promotes blood vessel growth). Common anti-VEGF drugs include bevacizumab and others used for similar eye conditions. These medications are injected directly into the eye—a procedure that sounds frightening but is performed with local anesthesia and has helped many patients preserve their vision. The injections work by stopping abnormal blood vessels from growing and leaking, thus preventing further damage to the retina.^[4][5]

Regular eye examinations are essential, typically recommended every few months or more frequently if active problems are detected. Patients are often taught to use an Amsler grid—a simple tool with a pattern of lines that helps detect distortions in vision that might signal bleeding or new blood vessel growth. If any changes appear, such as straight lines looking wavy or blurry spots developing, immediate medical attention is crucial. Early treatment of eye complications significantly improves the chances of preserving vision.^[11][16]

Cardiovascular Risk Reduction

PXE causes calcium deposits to build up in blood vessel walls, particularly affecting arteries. This process, similar to premature atherosclerosis (hardening of the arteries), can increase the risk of serious complications including heart attacks, strokes, and problems with blood flow to the limbs—a condition called intermittent claudication that causes cramping pain during walking or exercise.^[7]

Standard cardiovascular management focuses heavily on controlling risk factors that could accelerate blood vessel damage. This includes maintaining healthy cholesterol levels through diet and, when necessary, lipid-lowering medications such as statins. Blood pressure must be carefully monitored and controlled, as high blood pressure puts additional stress on already compromised blood vessels. Some patients require medication to manage hypertension, while others can achieve control through lifestyle changes alone.^[6][12]

Doctors typically recommend annual cardiovascular assessments, which may include blood tests to check cholesterol and other markers, echocardiograms (ultrasound examinations of the heart) to check valve function and heart muscle health, and sometimes stress tests to evaluate how the heart responds to exercise. These regular check-ups help detect problems early when they are easier to manage.^[16]

Lifestyle Modifications and Preventive Measures

Lifestyle changes form a critical component of PXE management. While these recommendations might seem straightforward, they can significantly impact disease progression and overall health outcomes. Regular physical exercise is particularly important—it helps maintain healthy blood flow, supports cardiovascular health, and can improve the body’s ability to compensate for reduced circulation in affected arteries. Walking and swimming are often recommended as excellent low-impact options that provide cardiovascular benefits without excessive strain.^[10][16]

Diet plays a crucial role as well. A balanced, low-fat diet rich in fruits and vegetables supports cardiovascular health and helps maintain healthy cholesterol levels. Some specialists recommend limiting calcium intake to moderate levels (around 800 mg daily for adults, though this may vary based on individual circumstances), as excessive dietary calcium could theoretically contribute to mineral deposits, though this remains an area of ongoing research and debate.^[16]

Managing Other Symptoms

The skin changes characteristic of PXE—yellowish bumps and loose, wrinkled skin particularly on the neck and flexural areas (like armpits, elbows, and behind the knees)—are generally harmless from a medical standpoint, though they can be cosmetically concerning. While these changes cannot be reversed, some people choose cosmetic procedures to address particularly bothersome skin laxity. Regular moisturizers help maintain skin health.^[13]

For patients who develop intermittent claudication (leg cramping with exercise), treatment focuses on exercise programs to build up collateral circulation—alternative pathways for blood flow. Walking through mild discomfort, then resting when pain becomes significant, helps the body develop these alternative routes. In some cases, doctors may prescribe pentoxifylline, a medication that improves blood flow, though it must be used cautiously due to potential bleeding risks.^[11]

Gastrointestinal bleeding, while rare, requires immediate medical attention. Patients are advised to watch for signs such as black, tarry stools or blood in vomit. When bleeding occurs, treatment may involve hospitalization, iron supplements for anemia, blood transfusions if needed, and in severe cases, endoscopic procedures or surgery to control the bleeding source.^[4]

Exploring New Horizons: Treatments Being Tested in Clinical Trials

While current standard treatments help manage symptoms, they do not address the fundamental metabolic defect that causes PXE. This has driven researchers to investigate novel therapeutic approaches that might target the underlying disease mechanisms. Several promising strategies are currently being explored, primarily in early-stage research and clinical trials.^[10]

Targeting the Metabolic Defect

Scientists have made significant progress in understanding what goes wrong in PXE at the molecular level. The condition is caused by mutations in the ABCC6 gene, which produces a protein important for transporting certain molecules across cell membranes, particularly in the liver and kidneys. When this protein doesn’t function properly, levels of pyrophosphate (PPi)—a natural substance that inhibits calcium deposits—become too low in the bloodstream. This shortage of PPi is thought to be a major reason why calcium accumulates inappropriately in elastic tissues.^[15][21]

Based on this understanding, researchers are investigating therapies aimed at increasing pyrophosphate levels or providing substances that mimic its anti-calcification effects. Some studies are exploring supplementation with magnesium and phosphate compounds, as these may influence the body’s mineral balance and calcification processes. Early research has also examined pyrophosphate analogs—synthetic compounds that work similarly to natural pyrophosphate—as potential treatments to prevent or slow abnormal calcification.^[10][21]

These metabolic approaches are still largely in preclinical development, meaning they are being tested in laboratory settings and animal models before moving to human trials. While promising in concept, substantial research is needed to determine whether these strategies are safe and effective for people with PXE.

Gene Therapy and Genetic Approaches

Because PXE is fundamentally a genetic disorder, scientists are exploring whether gene therapy—techniques to correct or compensate for faulty genes—might offer long-term solutions. Gene therapy approaches could potentially involve introducing functional copies of the ABCC6 gene into patients’ cells, allowing them to produce the missing or defective protein. Another emerging possibility is gene editing, which uses sophisticated molecular tools to correct mutations directly in a person’s DNA.^[10][15]

These approaches remain in early research stages, with most work currently focused on developing the techniques and testing safety in laboratory models. Gene therapy has shown promise for other genetic disorders, and researchers hope to adapt similar strategies for PXE. However, significant technical challenges remain, including ensuring the therapy reaches the right cells, produces adequate amounts of functional protein, and does so safely without causing unwanted side effects.

Pharmacological Chaperone Therapy

A particularly interesting experimental approach involves pharmacological chaperones—small molecules designed to help misfolded proteins achieve their proper shape and function. Some ABCC6 mutations cause the protein to fold incorrectly, leading to its breakdown before it can function. Chaperone molecules might stabilize these proteins, allowing them to work at least partially. This approach is being explored for various genetic diseases and represents a potential future option for PXE, though research in this area is still in early stages.^[15][21]

Advanced Eye Treatments

While anti-VEGF injections are now standard care for choroidal neovascularization in PXE, researchers continue to refine eye treatments. Clinical trials are evaluating different anti-VEGF medications, optimal dosing schedules, and combinations with other therapies to maximize vision preservation. Some studies are examining whether earlier or more aggressive treatment of subtle eye changes might prevent vision loss more effectively than waiting until problems become more severe.^[10]

Trial Phases and What They Mean

Clinical trials proceed through distinct phases, each designed to answer specific questions about a potential treatment. Phase I trials focus primarily on safety, involving small numbers of participants to determine whether a treatment causes harmful side effects and to establish appropriate dosing. Phase II trials expand to larger groups and begin evaluating whether the treatment actually works—does it improve symptoms, slow disease progression, or provide other benefits? Phase III trials involve even larger patient populations and compare the new treatment against current standard therapies to determine whether it offers advantages over existing options.^[10]

For PXE, most experimental treatments remain in early phases of development. The rarity of the condition presents challenges for clinical trial recruitment, as finding enough participants to generate meaningful results can be difficult. International collaboration and patient registries help connect researchers with potential trial participants across different countries and continents.

Most common treatment methods

• Eye treatments
  • Anti-VEGF injections (such as bevacizumab) into the eye to stop abnormal blood vessel growth and leakage
  • Regular eye examinations by retina specialists to monitor for complications
  • Use of Amsler grids for home monitoring of vision changes
  • Vitamin and mineral supplements (vitamins A, C, E, zinc) that may support retinal health
• Cardiovascular management
  • Lipid-lowering medications (statins) to control cholesterol levels
  • Blood pressure medications when needed to manage hypertension
  • Regular cardiovascular monitoring including echocardiograms and stress tests
  • Treatment with pentoxifylline for intermittent claudication (used with caution)
• Lifestyle modifications
  • Regular moderate exercise programs, particularly walking and swimming
  • Low-fat, heart-healthy diet rich in fruits and vegetables
  • Weight management to reduce cardiovascular strain
  • Smoking cessation (essential for all patients)
  • Moderate calcium intake (typically 600-800 mg daily, with adjustments based on individual needs)
• Preventive measures
  • Avoidance of aspirin and NSAIDs to reduce bleeding risk
  • Avoidance of contact sports and activities with head trauma risk
  • Careful monitoring for gastrointestinal bleeding signs
  • Annual comprehensive health assessments across multiple specialties
• Experimental approaches (in research)
  • Magnesium supplementation and phosphate binders to influence mineral metabolism
  • Pyrophosphate analogs to inhibit abnormal calcification
  • Gene therapy approaches to address the underlying genetic defect
  • Pharmacological chaperones to help misfolded proteins function properly